Body Dysmorphic Disorder
26
4
6
17
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
3.8%
1 terminated out of 26 trials
94.4%
+7.9% vs benchmark
12%
3 trials in Phase 3/4
53%
9 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (26)
Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns
CBT Effects on Neurophysiological and Psychological Outcomes in Body Dysmorphic Disorder
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
Individual Factors of CBT Underlying Success
Perceptual Abnormalities and Their Malleability in BDD
Smart-Phone Safety Behavior Fading Intervention for Appearance Concerns (Open ARSB Study)
When The Mirror Is Wrong
CBT for Muscle Dysmorphia and Steroid Abuse: A Randomized Controlled Trial
AI Screening for BDD in Aesthetic Surgery: Enhancing Safety and Outcomes
Online Cognitive Behavioural Therapy Intervention for Body Dysmorphic Disorder
Milk Thistle in Body Dysmorphic Disorder
Brain Correlates of Self-Focused Processing
Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)
Interpretation Bias Modification for Body Dysmorphic Disorder
Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder
Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder
D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
Oxytocin Administration in BDD and OCD
Fluoxetine in Pediatric Body Dysmorphic Disorder
Internet Delivered CBT for Body Dysmorphic Disorder